There may be an increase in vaccine hesitancy but it isn't too late for those who would still want them, one doctor says.

Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

According to the WHO, the proportion of the world’s population aged over 60 years will almost double, from 12% to 22%, ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

Health officials continue to encourage vaccinations to help prevent severe illnesses from influenza, RSV and COVID-19.

NPR's "Bill of the Month" thousands of questionable bills. Our crowdsourced investigation paved the way for landmark ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

Here are five key risk factors to know. Grandparents and grandkids share a special bond, but during respiratory virus season, older adults need to take extra care. People ages 65 and older are at ...

The illness can be mild to severe. (Info: CDC) Respiratory syncytial virus (RSV): A common respiratory virus that causes mild symptoms in most people, but it’s the leading cause of infant ...